Previous studies have produced conflicting findings, with some indicating an increased risk of RPL in women carrying specific thrombophilia mutations such as Factor V Leiden and Methylenetetrahydrofolate reductase (MTHFR), particularly in those with homozygous or compound heterozygous mutations [5,6,7,8,9]. This evidence concerns the gene MTHFR and thrombophilia.